Randall C. Schatzman, President and CEO at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 8,181 shares at $31.55 ($255K) on 2016-10-03, disclosed to the SEC on 2016-10-05.
Open-market sale of $255k ALDR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.95 | 5,481 | $170K | 66.6% |
| 2 | $31.55 | 2,700 | $85K | 33.4% |
| Total | $31.15 avg | 8,181 | $255K | 100% |
| Filing → |
| ALDR | SELL | 2016-11-09 | $252K | — | Filing → |
| ALDR | SELL | 2016-11-09 | $252K | — | Filing → |
| ALDR | SELL | 2016-10-05 | $170K | — | Filing → |